Laurence M. Boon

16.4k total citations · 1 hit paper
122 papers, 7.3k citations indexed

About

Laurence M. Boon is a scholar working on Surgery, Neurology and Oncology. According to data from OpenAlex, Laurence M. Boon has authored 122 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Surgery, 53 papers in Neurology and 49 papers in Oncology. Recurrent topics in Laurence M. Boon's work include Vascular Malformations and Hemangiomas (98 papers), Vascular Malformations Diagnosis and Treatment (52 papers) and Vascular Tumors and Angiosarcomas (40 papers). Laurence M. Boon is often cited by papers focused on Vascular Malformations and Hemangiomas (98 papers), Vascular Malformations Diagnosis and Treatment (52 papers) and Vascular Tumors and Angiosarcomas (40 papers). Laurence M. Boon collaborates with scholars based in Belgium, United States and France. Laurence M. Boon's co-authors include Miikka Vikkula, John B. Mulliken, O Enjolras, A. Dompmartin, Pascal Brouillard, Patricia E. Burrows, R Vanwijck, Matthew L. Warman, Bjørn R. Olsen and Nisha Limaye and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Laurence M. Boon

117 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2

1996 562 citations Miikka Vikkula, Laurence M. Boon et al. profile →

Peers

Laurence M. Boon

SURGE

NEURO

ONCOL

PFM

Francine Blei United States

Brian H. Kushner United States

Elisa Boscolo United States

Nisha Limaye Belgium

Robert Möhle Germany

James C. Nicholson United Kingdom

Kaan Gündüz Türkiye

R. Beverly Raney United States

André M. Oliveira United States

Martin Körbling United States

Francine Blei United States

Laurence M. Boon

2.9k ×0.5

SURGE

1.1k ×0.4

NEURO

1.1k ×0.4

ONCOL

875 ×0.6

PFM

292 ×0.3

Citations per year, relative to Laurence M. Boon Laurence M. Boon (= 1×) peers Francine Blei

Countries citing papers authored by Laurence M. Boon

Since Specialization

Citations

This map shows the geographic impact of Laurence M. Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence M. Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence M. Boon more than expected).

Fields of papers citing papers by Laurence M. Boon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence M. Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence M. Boon. The network helps show where Laurence M. Boon may publish in the future.

Co-authorship network of co-authors of Laurence M. Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence M. Boon. A scholar is included among the top collaborators of Laurence M. Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence M. Boon. Laurence M. Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andrade, Jorge, Ana Rita Grosso, Rui Benedito, et al.. (2025). Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Nature Cardiovascular Research. 4(7). 801–820. 4 indexed citations

Döring, Yvonne, André Schaller, Erik Vassella, et al.. (2024). Non‐Hotspot PIK3CA Variants Have Higher Variant Allele Frequency and are More Common in Syndromic Vascular Malformations. American Journal of Medical Genetics Part A. 197(2). e63883–e63883. 1 indexed citations

Seront, Emmanuel, Cédric Hermans, Laurence M. Boon, & Miikka Vikkula. (2024). Targeted treatments for vascular malformations: current state of the art. Journal of Thrombosis and Haemostasis. 22(11). 2961–2975. 9 indexed citations

Ivars, Marta, Nicole Revençu, Marie‐Cécile Nassogne, et al.. (2024). Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants. American Journal of Medical Genetics Part A. 194(6). e63551–e63551. 4 indexed citations

Brouillard, Pascal, Aino Murtomäki, Veli‐Matti Leppänen, et al.. (2024). Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. Journal of Clinical Investigation. 134(14). 2 indexed citations

Seront, Emmanuel, An Van Damme, Nicole Revençu, et al.. (2023). A case report of sirolimus use in early fetal management of lymphatic malformation. Nature Cardiovascular Research. 2(6). 595–599. 14 indexed citations

Seront, Emmanuel, An Van Damme, Catherine Legrand, et al.. (2023). Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations. JCI Insight. 8(21). 28 indexed citations

Giacalone, Guido, Raphaël Helaers, Salma Adham, et al.. (2023). Ureteropelvic junction obstruction with primary lymphoedema associated with CELSR1 variants. Journal of Medical Genetics. 60(12). 1161–1168. 3 indexed citations

Rößler, Jochen, et al.. (2023). Clinical phenotype of adolescent and adult patients with extracranial vascular malformation. Journal of Vascular Surgery Venous and Lymphatic Disorders. 11(5). 1034–1044.e3. 4 indexed citations

10.

Boon, Laurence M., Liliane Marot, Frank Hammer, et al.. (2022). Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations. Nature Cardiovascular Research. 1(6). 562–567. 24 indexed citations

11.

Boon, Laurence M., et al.. (2022). Molecular pathways and possible therapies for head and neck vascular anomalies. Journal of Oral Pathology and Medicine. 51(10). 878–887. 4 indexed citations

12.

Helaers, Raphaël, Christine Galant, Laurence M. Boon, et al.. (2021). KRAS-driven model of Gorham-Stout disease effectively treated with trametinib. JCI Insight. 6(15). 53 indexed citations

13.

Brouillard, Pascal, Matthieu J. Schlögel, Raphaël Helaers, et al.. (2021). Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations. Orphanet Journal of Rare Diseases. 16(1). 267–267. 32 indexed citations

14.

Queisser, Angela, Emmanuel Seront, Laurence M. Boon, & Miikka Vikkula. (2021). Genetic Basis and Therapies for Vascular Anomalies. Circulation Research. 129(1). 155–173. 120 indexed citations

15.

Smeland, Marie Falkenberg, Pascal Brouillard, Trine Prescott, et al.. (2021). Biallelic ANGPT2 loss-of-function causes severe early-onset non-immune hydrops fetalis. Journal of Medical Genetics. 60(1). 57–64. 5 indexed citations

16.

Seront, Emmanuel, et al.. (2020). Theranostic Advances in Vascular Malformations. Journal of Investigative Dermatology. 140(4). 756–763. 42 indexed citations

17.

Damme, An Van, et al.. (2020). New and Emerging Targeted Therapies for Vascular Malformations. American Journal of Clinical Dermatology. 21(5). 657–668. 67 indexed citations

18.

Martínez‐Corral, Inés, Yan Zhang, Henrik Ortsäter, et al.. (2020). Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation. Nature Communications. 11(1). 2869–2869. 70 indexed citations

19.

Seront, Emmanuel, Nisha Limaye, Laurence M. Boon, & Miikka Vikkula. (2016). La rapamycine ouvre l’ère des thérapies ciblées dans les malformations veineuses. médecine/sciences. 32(6-7). 574–578. 2 indexed citations

20.

Brouillard, Pascal, Laurence M. Boon, & Miikka Vikkula. (2014). Genetics of lymphatic anomalies. Journal of Clinical Investigation. 124(3). 898–904. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact